bluebird bio, Inc. (BLUE) Financials

BLUE Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 613.6 million 391.1 million
2023-06-30 663.4 million 374.4 million
2023-03-31 692.7 million 338.0 million
2022-12-31 554.9 million 358.6 million

BLUE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -63.9 million 4.9 million
2023-06-30 -73.4 million 5.8 million
2023-03-31 -87.7 million 5.4 million
2022-12-31 -61.4 million 4.7 million

BLUE Net Income

No data available :(

BLUE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 174.3 million - 303.7 million
2023-06-30 245.3 million - 306.9 million
2023-03-31 318.3 million - 273.4 million
2022-12-31 181.7 million - 281.4 million

BLUE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 109.1 million
2023-06-30 108.7 million
2023-03-31 103.3 million
2022-12-31 85.2 million

BLUE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 2.0 million 45.5 million 40.7 million -
2023-06-30 705000 42.3 million 40.3 million -
2023-03-31 1.1 million 46.1 million 37.4 million -
2022-12-31 5.1 million 45.9 million 30.7 million -

BLUE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 12.4 million 11.0 million
2023-06-30 6.9 million 9.6 million
2023-03-31 2.4 million 3.4 million
2022-12-31 62000 22000

BLUE

Price: $0.92

52 week price:
0.88
5.53

Payout Ratio Range:
-15.05%
-7.76%

Earnings Per Share: -0.63 USD

P/E Ratio: -1.52

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 3.0 million

Ebitda: -74.0 million

Market Capitalization: 227.4 million

Links: